Antiviral therapy in 38 HCV infected childhood cancer survivors
Treatment . | No. patients . | Responders . | Nonresponders . | On therapy . |
|---|---|---|---|---|
| IFN | 20 | 6 | 14* | 0 |
| IFN + ribavirin | 16 | 7 | 9† | 0 |
| Primary therapy | 12 | 5 | 7 | 0 |
| Secondary therapy | 4 | 2 | 2 | 0 |
| PEG-IFN + ribavirin | 11 | 4 | 2‡ | 5 |
| Primary therapy | 6 | 3 | 0 | 3 |
| Secondary therapy | 5 | 1 | 2 | 2 |
Treatment . | No. patients . | Responders . | Nonresponders . | On therapy . |
|---|---|---|---|---|
| IFN | 20 | 6 | 14* | 0 |
| IFN + ribavirin | 16 | 7 | 9† | 0 |
| Primary therapy | 12 | 5 | 7 | 0 |
| Secondary therapy | 4 | 2 | 2 | 0 |
| PEG-IFN + ribavirin | 11 | 4 | 2‡ | 5 |
| Primary therapy | 6 | 3 | 0 | 3 |
| Secondary therapy | 5 | 1 | 2 | 2 |
Abbreviations: IFN, interferon; PEG-IFN, pegylated interferon.
Includes 2 patients unable to complete therapy because of psychosis (1) or depression (1)
Includes 2 patients unable to complete therapy due to severe anemia (1) and hypothyroidism (1)
Includes 1 patient unable to complete therapy due to depression; this patient was also taken off interferon for the same reason